Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)

Historic Asset Utilization Ratio for InMed Pharmaceuticals (INM) over the last 4 years, with Q4 2025 value amounting to 0.37.

  • InMed Pharmaceuticals' Asset Utilization Ratio fell 2795.04% to 0.37 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.37, marking a year-over-year decrease of 2795.04%. This contributed to the annual value of 0.36 for FY2025, which is 172.03% up from last year.
  • InMed Pharmaceuticals' Asset Utilization Ratio amounted to 0.37 in Q4 2025, which was down 2795.04% from 0.33 recorded in Q3 2025.
  • Over the past 5 years, InMed Pharmaceuticals' Asset Utilization Ratio peaked at 0.55 during Q1 2025, and registered a low of 0.08 during Q2 2022.
  • For the 4-year period, InMed Pharmaceuticals' Asset Utilization Ratio averaged around 0.33, with its median value being 0.37 (2025).
  • As far as peak fluctuations go, InMed Pharmaceuticals' Asset Utilization Ratio skyrocketed by 30898.32% in 2023, and later tumbled by 2795.04% in 2025.
  • InMed Pharmaceuticals' Asset Utilization Ratio (Quarter) stood at 0.1 in 2022, then surged by 308.98% to 0.42 in 2023, then rose by 21.52% to 0.51 in 2024, then fell by 27.95% to 0.37 in 2025.
  • Its last three reported values are 0.37 in Q4 2025, 0.33 for Q3 2025, and 0.4 during Q2 2025.